Skip to search formSkip to main contentSkip to account menu

Behcet Syndrome

Known as: Complices, Triple Symptom, Symptom Complices, Triple, Disease, Behçet 
Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the… 
National Institutes of Health

Related topics

Related topics

17 relations
Aphthous StomatitisAutoimmune DiseasesIn BloodInflammation

Narrower (1)

Arthropathy in Behcet's Syndrome

Broader (4)

Dermatologic disordersSyndromeUnspecified infectious and parasitic diseasesUveitis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Interleukin 37 has been found to play a significant regulatory role in the innate immune response. It is not yet known whether IL… 
Review
2011
Review
2011
EFFICACY AND SAFETY OF INTRAVITREAL BEVACIZUMAB COMPARED WITH INTRAVITREAL AND POSTERIOR SUB-TENON TRIAMCINOLONE ACETONIDE FOR TREATMENT OF UVEITIC CYSTOID MACULAR EDEMA
Purpose: To demonstrate the effect of bevacizumab compared with triamcinolone acetonide for the treatment of persistent cystoid… 
Highly Cited
2011
Highly Cited
2011
MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases.
Review
2010
Review
2010
Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behçet's disease on infliximab therapy
Aim To evaluate the efficacy of infliximab treatment in patients with refractory uveoretinitis associated with Behçet's disease… 
Review
2007
Review
2007
Can a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores be informative in patients with all rheumatic diseases?
  • T. PincusT. Sokka
  • Baillière's Best Practice & Research : Clinical…
  • 2007
  • Corpus ID: 1372017
Review
2005
Review
2005
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a review.
Highly Cited
2004
Highly Cited
2004
Short CommunicationThe MCP-1 Promoter -2518 Polymorphism in Behcet's Disease: Correlation Between Allele Types, MCP-1 Production and Clinical Symptoms among Korean Patients
Objective: To compare the G vs. A variation at the MCP-1 promoter -2518 position among normal Koreans and Behcet patients, and to… 
2001
2001
Interferon-alpha 2a treatment of neuro-Behcet disease.
Behcet disease is a multisystemic, chronic, recurrent inflammatory disorder characterized as a triad of hypopyon uveitis, oral… 
Highly Cited
1984
Highly Cited
1984
CHLORAMBUCIL-INDUCED CHROMOSOME DAMAGE TO HUMAN LYMPHOCYTES IS DOSE-DEPENDENT AND CUMULATIVE
Highly Cited
1979
Highly Cited
1979
Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
Six patients with necrotizing vasculitis were treated with oral colchicine as part of an open study. Four patients with cutaneous… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)